Patents by Inventor Regis Millet

Regis Millet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P2RX7 modulators in therapy
    Patent number: 11919854
    Abstract: The present invention relates to compounds of formula (I), their enantiomers and their pharmaceutically acceptable salts, and their use in therapy, particularly for the treatment of cancer or inflammatory diseases.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: March 5, 2024
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, CHRU DE LILLE, UNIVERSITE COTE D'AZUR, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE DE LILLE, JUNIA
    Inventors: Valérie Vouret, Laetitia Douguet, Alina Ghinet, Germain Homerin, Benoît Guy Marie Rigo, Davy Jérémy Baudelet, Xavier Dezitter, Régis Millet, Christophe Furman
  • P2RX7 MODULATORS IN THERAPY
    Publication number: 20210017131
    Abstract: The present invention relates to compounds of formula (I), their enantiomers and their pharmaceutically acceptable salts, and their use in therapy, particularly for the prevention and/or treatment of cancer or inflammatory diseases.
    Type: Application
    Filed: March 29, 2019
    Publication date: January 21, 2021
    Inventors: Valérie Vouret, Laetitia Douguet, Alina Ghinet, Germain Homerin, Benoît Guy Marie Rigo, Davy Jérémy Baudelet, Xavier Dezitter, Régis Millet, Christophe Furman
  • DERIVATIVES OF 2H-PYRAZOLO[4,3-C]QUINOLIN-3(5H)-ONE AND USE THEREOF
    Publication number: 20170137419
    Abstract: The invention relates to compounds of formula (I) or the pharmaceutically acceptable solvates thereof, as well as to the use thereof as a drug.
    Type: Application
    Filed: June 11, 2015
    Publication date: May 18, 2017
    Inventors: Régis Millet, Philippe Chavatte, Pierre Desreumaux, Mathilde Body, Jamal El Bakali
  • 1,4-Dihydropyridine Derivatives and Their Uses
    Publication number: 20120149735
    Abstract: The present invention relates to 1,4-dihydropyridine derivatives of the formula (I) and their uses in the treatment and/or prevention of diseases and disorders directly or indirectly associated with the modification (increase or decrease) of the activity of the cannabinoid receptor 2 (CB2).
    Type: Application
    Filed: May 19, 2010
    Publication date: June 14, 2012
    Applicants: CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE, UNIVERSITE LILLE 2 DROIT ET SANTE
    Inventors: Regis Millet, Jamal El Bakali, Philippe Chavatte, Nicolas Renault, Didier Lambert, Giulo Muccioli, Mathilde Body-Malapel, Pierre Desreumaux